Evidence map›Paper›PMID 30633196›Full record

ArticleMedicine2019

Chronic active EBV infection associated with NK cell lymphoma and hemophagocytic lymphohistiocytosis in a 27-year-old woman: A case report.

Ya-Dong Wang, Ling-Ling Wu, Lu-Yuan Ma, Xiao-Bo Shang, Zi-Yue Li, Wei Wang, Chuan Shen, Jing-Jing Yang, Li-Xia Sun, Cai-Yan Zhao

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ya-Dong WangDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Ling-Ling WuDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Lu-Yuan MaDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Xiao-Bo ShangDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Zi-Yue LiDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Wei WangDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Chuan ShenDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Jing-Jing YangDepartment of Infectious Diseases, Nanpi County Hospital, Cangzhou.
Li-Xia SunDepartment of Hematopathology, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang, China.
Cai-Yan ZhaoDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang.
Hebei Medical University · CNThird Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleChronic active Epstein-Barr virus infection (CAEBV) is a common infectious disease that often affects multiple organs or systems. However, it is liable to be neglected and misdiagnosed owing to its insidious onset, lack of specific findings in the early phase, and a general lack of awareness among clinicians. PATIENT CONCERNS:: a 27-year-old woman case has been described who was initially misdiagnosed as drug-induced liver injury due to onset presentation of mild splenomegaly, recurrent liver dysfunction, and disputable pathological evidence of liver biopsy. DIAGNOSES: CAEBV complicated with natural killer (NK) cell lymphoma and hemophagocytic lymphohistiocytosis (HLH) was diagnosed by in situ hybridization of liver tissue section with EBV-encoded RNA -1 probe and flow cytometry of bone marrow.

interventionsAfter admission, the patient received symptomatic treatment and antiviral therapy (combination of acyclovir and foscarnet sodium) as well as adjuvant treatment (thymosin alpha 1 and methylprednisolone); later, the patient received etoposide and dexamethasone for diagnosis of EBV associated HLH. Subsequently, the disease progressed to NK cell lymphoma and the patient received the revised EPOCH chemotherapy regimen [etoposide (100 mg/d, d1-5), dexamethasone (7.5 mg/d, d1-5; 5 mg/d, d6-14), cyclophosphamide (0.8 g/d, d1-2), and pegaspargase (3750 u/d, tid, d1-2)]. OUTCOMES: Although the patient received a series of therapies and other comprehensive measures, finally she died of gastrointestinal hemorrhage and multiple organ failure. LESSONS: Liver is one of the main target organs of EBV infection. In the clinical setting of unexplained fever and liver injury, it is necessary to be aware of CAEBV, as well as its fatal complication such as EBV associated NK cell lymphoma and HLH.

Indexed as

AdultChronic DiseaseDiagnosis, DifferentialEpstein-Barr Virus InfectionsFatal OutcomeFemaleHumansLymphohistiocytosis, HemophagocyticLymphoma

Identifiers

PMID30633196
PMCPMC6336602
OpenAlexW3003371771

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.